Amiodarone to prevent heart rhythm problems after cardiac arrest
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving the drug amiodarone early can prevent dangerous heart rhythm problems in patients who survived a cardiac arrest with a shockable rhythm. If it works, it could help more people recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be in the intensive care unit after a cardiac arrest that happened outside the hospital
- Your heart had a rhythm that could be shocked (ventricular fibrillation or pulseless ventricular tachycardia)
- The cause of the arrest is likely from your heart or is unknown
- You must be able to start the study drug within 6 hours of getting your heartbeat back
- You or a family member must agree to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving the heart rhythm medicine amiodarone early after a shockable cardiac arrest improves survival. If you had a cardiac arrest due to a heart rhythm problem that didn't stop after the first shock, this study may be for you.
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
This trial tests if giving the medication amiodarone before and after heart surgery can prevent a common complication called atrial fibrillation (an irregular heartbeat). It is for people who do not already have atrial fibrillation and are having heart surgery that is not coronary artery bypass.
This trial studies whether a short course of amiodarone started right after heart surgery can reduce problems from new-onset atrial fibrillation (a common fast heart rhythm) or flutter. It may help some patients avoid ongoing rhythm issues and improve recovery soon after discharge.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
This trial tests if placing a small amount of amiodarone medicine near the heart during open-chest surgery can help prevent a common irregular heartbeat (atrial fibrillation) that often happens after heart surgery.
Hear when a new Ventricular Arrhythmias and Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.